Phase I study of phenylacetate administered twice daily to patients with cancer.
Thibault, A
Phase I study of phenylacetate administered twice daily to patients with cancer. [electronic resource] - Cancer Jun 1995 - 2932-8 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p doi
Adult
Aged
Antineoplastic Agents--administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms--drug therapy
Phenylacetates--administration & dosage
Phase I study of phenylacetate administered twice daily to patients with cancer. [electronic resource] - Cancer Jun 1995 - 2932-8 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0008-543X
10.1002/1097-0142(19950615)75:12<2932::aid-cncr2820751221>3.0.co;2-p doi
Adult
Aged
Antineoplastic Agents--administration & dosage
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasms--drug therapy
Phenylacetates--administration & dosage